M. Jain

Epidemiology · Journal of Clinical Investigation · 2004–2011

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Jain trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. P. Ridker
  2. M. Hayden
  3. G. Owens

Who trusts M. Jain overall

  1. Lei Xie

Papers from M. Jain's perspective

Ordered by how strongly the researchers M. Jain trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The evolving role of statins in the management of atherosclerosis. (Journal of the American College of Cardiology)
  2. NF-κB: pivotal mediator or innocent bystander in atherogenesis?
  3. Statins and the risk of colorectal cancer. (New England Journal of Medicine)
  4. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. (Proceedings of the National Academy of Sciences of the United States of America)
  5. Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization (Circulation)
  6. Structural Mechanism for Statin Inhibition of HMG-CoA Reductase (Science)
  7. Signaling to NF-kappaB. (Genes & Development)
  8. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. (Cell Metabolism)
  9. Rho kinase, a promising drug target for neurological disorders (Nature reviews. Drug discovery)
  10. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. (Physiological Reviews)

Their papers